EMEA-002435-PIP01-18-M02

Table of contents

Key facts

Active substance
Eladocagene exuparvovec
Therapeutic area
Neurology
Decision number
P/0074/2021
PIP number
EMEA-002435-PIP01-18-M02
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Treatment of aromatic L-amino acid decarboxylase deficiency
Route(s) of administration
Intracerebral use
Contact for public enquiries
PTC Therapeutics International Limited

Tel. +353 19068700
E-mail: medinfo@ptcbio.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating